The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Vitamin D and Multiple Sclerosis: A Comprehensive Review
Open accessAbstract
Numerous observational studies have suggested that there is a correlation between the level of serum vitamin D and MS risk and disease activity. To explore this hypothesis, a literature search of large, prospective, observation studies, epidemiological studies, and studies using new approaches such as Mendelian randomization was conducted. Available data and ongoing research included in this review suggest that the level of serum vitamin D affects the risk of developing MS and also modifies disease activity in MS patients. Newer Mendelian randomization analyses suggest there is a causal relationship between low vitamin D level and the risk of MS. Post-hoc evaluations from two phase 3 studies, BENEFIT and BEYOND, support the findings of observational trials. Study limitations identified in this review recognize the need for larger controlled clinical trials to establish vitamin D supplementation as the standard of care for MS patients. Though there is increasing evidence indicating that lower vitamin D levels are associated with increased risk of MS and with greater clinical and brain MRI activity in established MS, the impact of vitamin D supplementation on MS activity remains inadequately investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Vitamin effects on the immune system: Vitamins A and D take centre stage
Mora, J. R., Iwata, M., & von Andrian, U. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2378 · Cited by 1,559 · cited 4×
“Reprinted by permission from Macmillan Publishers Ltd: [14] 62 Neurol Ther (2018) 7:59–85”
BackgroundInfluentialHuman serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F., & Barger-Lux, M. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.204 · Cited by 1,396
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdova, E., Kita, M., Yang, M., Raghupathi, K., Novas, M., Sweetser, M. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206328 · Cited by 1,355
Vitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319 · cited 1×
“UVB in the 290–315-nm range photolyses 7-dehydrocholesterol in the skin to form previtamin D3, which then isomerizes to vitamin D3 or cholecalciferol [8].”
BackgroundVitamin D for health: a global perspective
Hossein-nezhad, A., & Holick, M. F. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.011 · Cited by 1,298
Vitamin D intake and incidence of multiple sclerosis
Munger, K. L., Zhang, S. M., O’Reilly, E., Hernán, M. A., Olek, M. J., Willett, W. C., & Ascherio, A. (2004) · Neurology · doi:10.1212/01.wnl.0000101723.79681.38 · Cited by 1,093
Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation
Wacker, M., & Holick, M. (2013) · Nutrients · doi:10.3390/nu5010111 · Cited by 733
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
Kappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237641.33768.8d · Cited by 681
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Kappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.003 · Cited by 549
The case against ergocalciferol (vitamin D2) as a vitamin supplement1,2
Houghton, L. A., & Vieth, R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.694 · Cited by 530
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Ascherio, A., Munger, K. L., White, R., Köchert, K., Simon, K. C., Polman, C. H., Freedman, M. S., Hartung, H.-P., Miller, D. H., Montalbán, X., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5993 · Cited by 516
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Bauer, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61194-5 · Cited by 502
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H., Dwyer, T., Gies, P., & van der Mei, I. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 457
Timing of birth and risk of multiple sclerosis: population based study
Willer, C. J., Dyment, D. A., Sadovnick, A. D., Rothwell, P. M., Murray, T. J., & Ebers, G. C. (2005) · BMJ · doi:10.1136/bmj.38301.686030.63 · Cited by 451
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
Mokry, L. E., Ross, S., Ahmad, O. S., Forgetta, V., Smith, G. D., Leong, A., Greenwood, C. M. T., Thanassoulis, G., & Richards, J. B. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001866 · Cited by 445 · cited 3×
“An increase of 25(OH)D levels by 50% decreased the odds of getting MS by approximately 50% [42, 44].”
BackgroundFunctional indices of vitamin D status and ramifications of vitamin D deficiency
Heaney, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1706s · Cited by 430
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Metzig, C., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70237-6 · Cited by 369
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
Burton, J. M., Kimball, S., Vieth, R., Bar-Or, A., Dosch, H.-M., Cheung, R., Gagne, D., D'Souza, C., Ursell, M., & O'Connor, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e1cec2 · Cited by 360
Sun exposure and vitamin D are independent risk factors for CNS demyelination
Lucas, R. M., Ponsonby, A.-L., Dear, K., Valery, P. C., Pender, M. P., Taylor, B. V., Kilpatrick, T. J., Dwyer, T., Coulthard, A., Chapman, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31820af93d · Cited by 358
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., & Hupperts, R. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508094399 · Cited by 340
Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis
Mowry, E. M., Krupp, L. B., Milazzo, M., Chabas, D., Strober, J. B., Belman, A. L., McDonald, J. C., Oksenberg, J. R., Bacchetti, P., & Waubant, E. (2010) · Annals of Neurology · doi:10.1002/ana.21972 · Cited by 329
New insights into the mechanisms of vitamin D action
Christakos, S., Dhawan, P., Liu, Y., Peng, X., & Porta, A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10423 · Cited by 324
Swank, R. L., Lerstad, O., Strøm, A., & Backer, J. (1952) · New England Journal of Medicine · doi:10.1056/nejm195205082461901 · Cited by 317
Iron Deposition Leads to Neuronal α-Synuclein Pathology by Inducing Autophagy Dysfunction
Wan, W., Jin, L., Wang, Z., Wang, L., Fei, G., Ye, F., Pan, X., Wang, C., & Zhong, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00001 · Cited by 299
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Mowry, E. M., Waubant, E., McCulloch, C. E., Okuda, D. T., Evangelista, A. A., Lincoln, R. R., Gourraud, P., Brenneman, D., Owen, M. C., Qualley, P., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23591 · Cited by 270
Soilu-Hänninen, M., Åivo, J., Lindström, B.-M., Elovaara, I., Sumelahti, M.-L., Färkkilä, M., Tienari, P., Atula, S., Sarasoja, T., Herrala, L., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301876 · Cited by 269
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis
Runia, T. F., Hop, W. C. J., de Rijke, Y. B., Buljevac, D., & Hintzen, R. Q. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fdec7 · Cited by 229
Safety of vitamin D3 in adults with multiple sclerosis
Kimball, S. M., Ursell, M. R., O’Connor, P., & Vieth, R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.645 · Cited by 227
van der Mei, I. A. F., Ponsonby, A.-L., Blizzard, L., & Dwyer, T. (2001) · Neuroepidemiology · doi:10.1159/000054783 · Cited by 216
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk
Rhead, B., Bäärnhielm, M., Gianfrancesco, M., Mok, A., Shao, X., Quach, H., Shen, L., Schaefer, C., Link, J., Gyllenberg, A., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000097 · Cited by 212
van Loon, R. B., Veen, G., Baur, L. H. B., Kamp, O., Bronzwaer, J. G. F., Twisk, J. W. R., Verheugt, F. W. A., & van Rossum, A. C. (2012) · Trials · doi:10.1186/1745-6215-13-1 · Cited by 203
Kampman, M. T., Steffensen, L. H., Mellgren, S. I., & Jørgensen, L. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511434607 · Cited by 200
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
Stein, M. S., Liu, Y., Gray, O. M., Baker, J. E., Kolbe, S. C., Ditchfield, M. R., Egan, G. F., Mitchell, P. J., Harrison, L. C., Butzkueven, H., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343274 · Cited by 185
Munger, K. L., Åivo, J., Hongell, K., Soilu-Hänninen, M., Surcel, H.-M., & Ascherio, A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4800 · Cited by 178
Association of UV radiation with multiple sclerosis prevalence and sex ratio in France
Orton, S. M., Lucien Wald, A., Confavreux, C., Vukusic, S., Krohn, J., Ramagopalan, S. V., Herrera, B. M., Sadovnick, A. D., & Ebers, G. C. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0a9f · Cited by 172
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS
Gianfrancesco, M. A., Stridh, P., Rhead, B., Shao, X., Xu, E., Graves, J. S., Chitnis, T., Waldman, A., Lotze, T., Schreiner, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003849 · Cited by 168
Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis
Smolders, J., Peelen, E., Thewissen, M., Cohen Tervaert, J. W., Menheere, P., Hupperts, R., & Damoiseaux, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015235 · Cited by 166
Fitzgerald, K. C., Munger, K. L., Köchert, K., Arnason, B. G. W., Comi, G., Cook, S., Goodin, D. S., Filippi, M., Hartung, H.-P., Jeffery, D. R., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2742 · Cited by 161
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
Pierrot-Deseilligny, C., & Souberbielle, J.-C. (2010) · Brain · doi:10.1093/brain/awq147 · Cited by 161
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis
Sotirchos, E. S., Bhargava, P., Eckstein, C. P., van Haren, K. P., Baynes, M., Ntranos, A., Gocke, A. R., Steinman, L., Mowry, E. M., & Calabresi, P. A. (2015) · Neurology · doi:10.1212/wnl.0000000000002316 · Cited by 157
Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MIS
Kurtzke, J. F., Beebe, G. W., & Norman, J. E. (1985) · Neurology · doi:10.1212/wnl.35.5.672 · Cited by 153
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
Martinelli, V., Costa, G. D., Colombo, B., Libera, D. D., Rubinacci, A., Filippi, M., Furlan, R., & Comı, G. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513494959 · Cited by 138
Regional variations in the prevalence of multiple sclerosis in French farmers
Vukusic, S., Bockstael, V. V., Gosselin, S., & Confavreux, C. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.101196 · Cited by 137
Koch, M. W., Mostert, J. P., de Vries, J. J., & Keyser, J. D. (2007) · Neurology · doi:10.1212/01.wnl.0000261131.23708.1c · Cited by 129
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis
Pierrot‐Deseilligny, C., & Souberbielle, J. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612473513 · Cited by 118
Intramedullary spinal cord neurocysticercosis presenting as Brown-Séquard syndrome
Noguera, E. M. S., Sic, R. P., & Solis, F. E. (2015) · BMC Neurology · doi:10.1186/s12883-014-0245-5 · Cited by 111
Protective role of the vitamin D receptor
Yang, L., Ma, J., Zhang, X., Fan, Y., & Wang, L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.10.002 · Cited by 107
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
Løken-Amsrud, K. I., Holmøy, T., Bakke, S. J., Beiske, A. G., Bjerve, K. S., Bjørnarå, B. T., Hovdal, H., Lilleås, F., Midgard, R., Pedersen, T., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fdf01 · Cited by 107
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis
James, E., Dobson, R., Kühle, J., Baker, D., Giovannoni, G., & Ramagopalan, S. V. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513489756 · Cited by 105
Dörr, J., Ohlraun, S., Skarabis, H., & Paul, F. (2012) · Trials · doi:10.1186/1745-6215-13-15 · Cited by 103
Jelinek, G. A., Marck, C. H., Weiland, T. J., Pereira, N. G., van der Meer, D. M., & Hadgkiss, E. J. (2015) · BMC Neurology · doi:10.1186/s12883-015-0394-1 · Cited by 77
Shaygannejad, V., Janghorbani, M., Ashtari, F., & Dehghan, H. (2012) · Multiple Sclerosis International · doi:10.1155/2012/452541 · Cited by 76
Laursen, J. H., Søndergaard, H. B., Sørensen, P. S., Sellebjerg, F. T., & Oturai, A. B. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.10.005 · Cited by 76
DISTRIBUTION AND MORTALITY TIME TREND OF MULTIPLE SCLEROSIS AND SOME OTHER DISEASES IN NORWAY
WESTLUND, K. B. (1970) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1970.tb05806.x · Cited by 70
Bhargava, P., Cassard, S., Steele, S. U., Azevedo, C., Pelletier, D., Sugar, E. A., Waubant, E., & Mowry, E. M. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.10.004 · Cited by 69
Clinical utility of vitamin d testing: an evidence-based analysis.
(2010) · Europe PMC (PubMed Central) · Cited by 67
Hauser, S. L., Weiner, H. L., Che, M., SHAPIRO, M. E., Gilles, F. H., & Letvin, N. L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1276 · Cited by 57
Molecular mechanism underlying the impact of vitamin D on disease activity of MS
Munger, K. L., Köchert, K., Simon, K. C., Kappos, L., Polman, C. H., Freedman, M. S., Hartung, H. P., Miller, D. H., Montalbán, X., Edan, G., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.91 · Cited by 57
Prevention and treatment of MS: studying the effects of vitamin D
Munger, K. L., & Ascherio, A. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511425366 · Cited by 57
Effect of vitamin D on MS activity by disease-modifying therapy class
Rotstein, D., Healy, B. C., Malik, M. T., Carruthers, R. L., Musallam, A., Kivisäkk, P., Weiner, H. L., Glanz, B. I., & Chitnis, T. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000167 · Cited by 55
Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients
Darwish, H., Haddad, R., Osman, S., Ghassan, S., Yamout, B., Tamim, H., & Khoury, S. J. (2017) · Scientific Reports · doi:10.1038/srep45926 · Cited by 52
Etemadifar, M., & Janghorbani, M. (2015) · PubMed Central · Cited by 43
Prolonged vitamin D intoxication: presentation, pathogenesis and progress
Bell, D. A., Crooke, M. J., Hay, N., & Glendenning, P. (2013) · Internal Medicine Journal · doi:10.1111/imj.12269 · Cited by 29
Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.
Harandi, A. A., Shahbeigi, S., Pakdaman, H., Fereshtehnejad, S., Nikravesh, E., & Jalilzadeh, R. (2012) · PubMed Central · Cited by 28
Vitamin d3 concentration correlates with the severity of multiple sclerosis.
Shahbeigi, S., Pakdaman, H., Fereshtehnejad, S., Nikravesh, E., Mirabi, N., & Jalilzadeh, G. (2013) · PubMed Central · Cited by 25
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom
Cruz, P. M. R., Matthews, L., Boggild, M., Cavey, A., Constantinescu, C. S., Evangelou, N., Giovannoni, G., Gray, O. M., Hawkins, S. A., Nicholas, R. S., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1463 · Cited by 23
Confounding in association studies: month of birth and multiple sclerosis
Fiddes, B., Wason, J. M. S., & Sawcer, S. J. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7241-y · Cited by 22
Vitamin D and Long-Term Memory in Multiple Sclerosis
Koven, N. S., Cadden, M. H., Murali, S. G., & Ross, M. K. (2013) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000009 · Cited by 19
Determining Causation from Observational Studies: A Challenge for Modern Neuroepidemiology
Jelinek, G. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00265 · Cited by 18
Treatment of Multiple Sclerosis – Relationship between Vitamin D and Interferon β-1b
Taylor, B. V., Moses, H., Paul, F., Suarez, G., & Rametta, M. (2015) · European Neurological Review · doi:10.17925/enr.2015.10.02.124 · Cited by 4
Self-citationA gestational dose of vitamin D per day keeps the MS doctor away
Marrie, R. A., & Däumer, M. (2016) · Neurology · doi:10.1212/wnl.0000000000003469 · Cited by 4
Cited by
Dobson, R., & Giovannoni, G. (2019) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,148
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Environmental and genetic risk factors for MS: an integrated review
Waubant, E., Lucas, R., Mowry, E., Graves, J., Olsson, T., Alfredsson, L., & Langer‐Gould, A. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50862 · Cited by 340
Onisiforou, A., & Spyrou, G. M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab141 · Cited by 23
Multiple sclerosis risk with air pollution
(2021) · Journal of Multiple Sclerosis · doi:10.35248/2376-0389.21.8.236
Metadata
- Authors
- Sintzel, M. B., Rametta, M., & Reder, A. T.
- Venue
- Neurology and Therapy
- Published
- 2017-12-14
- Volume
- 7
- Issue
- 1
- Pages
- 59-85
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- OpenAlex
- W2775648299
- Cited by
- 435
- References
- 79
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.